DermaSensor™ quickly assesses information below the skin surface to give physicians more information in their decision-making.
DermaSensor™ is designed to improve early detection of skin cancer by helping clinicians to refer or biopsy skin cancer earlier and DermaSensor™ may also reduce the number of unnecessary referrals and biopsies.
Patients are expected to view DermaSensor™ as a supplemental and valuable addition to the skincare they already receive.
The non-invasive nature of DermaSensor™ is expected to be unintimidating to patients and reassure them that they are receiving high-quality care.
The machine-learning algorithm is derived from thousands of spectral samples of pathologically-verified lesions and is trained by expert data scientists.